propantheline has been researched along with Fistula in 2 studies
Propantheline: A muscarinic antagonist used as an antispasmodic, in rhinitis, in urinary incontinence, and in the treatment of ulcers. At high doses it has nicotinic effects resulting in neuromuscular blocking.
Fistula: Abnormal communication most commonly seen between two internal organs, or between an internal organ and the surface of the body.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BOBA, A | 2 |
| KORKOSZ, AB | 2 |
| Pendleton, RG | 1 |
| Bartakovits, P | 1 |
| Miller, DA | 1 |
| Mann, WA | 1 |
| Ridley, PT | 1 |
2 other studies available for propantheline and Fistula
| Article | Year |
|---|---|
Propantheline bromide (pro-banthine), an adjuvant in the treatment of pancreaticoduodenal fistulas.
Topics: Adjuvants, Immunologic; Adjuvants, Pharmaceutic; Duodenum; Fistula; Humans; Pancreas; Parasympatholy | 1957 |
Propantheline bromide (pro-banthine), an adjuvant in the treatment of pancreaticoduodenal fistulas.
Topics: Adjuvants, Immunologic; Adjuvants, Pharmaceutic; Duodenum; Fistula; Humans; Pancreas; Parasympatholy | 1957 |
Propantheline bromide (pro-banthine), an adjuvant in the treatment of pancreaticoduodenal fistulas.
Topics: Adjuvants, Immunologic; Adjuvants, Pharmaceutic; Duodenum; Fistula; Humans; Pancreas; Parasympatholy | 1957 |
Propantheline bromide (pro-banthine), an adjuvant in the treatment of pancreaticoduodenal fistulas.
Topics: Adjuvants, Immunologic; Adjuvants, Pharmaceutic; Duodenum; Fistula; Humans; Pancreas; Parasympatholy | 1957 |
Studies indicating a central antisecretory site of action for desmethylimipramine (DMI).
Topics: Animals; Carbachol; Chlorpromazine; Desipramine; Dogs; Electric Stimulation; Female; Fistula; Gastri | 1970 |